LLY logo

LLY Eli Lilly and Company

New York Stock Exchange · Drug Manufacturers - General · Healthcare

$1347.11
-4.01 (-0.30%)

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (includi…

Market Cap: $1.27Twww.lilly.com

Price

$1347.11+9.20%
$1115.70$1224.97$1334.23$1443.50
Aug 25Nov 20

Social Signal Score

46
5d
41
11 mentions
-4.8%
30d
46
91 mentions
+5.8%
60d
49
188 mentions
+17.0%
90d
49
248 mentions
+8.0%
news: 146 · marketaux: 14 · rss: 13 · 4chan: 75

Analyst Ratings

46 analysts
Buyconsensus
Strong Buy 0Buy 34Hold 9Sell 3Strong Sell 0
Avg price target$1,448+7.5%
Low $940Median $1,450High $1,650
Current Consensus

52-week range

$851.21$1443.50
Last close
$1347.11
Off 52w high
-6.7%
200-day average
$1117.90
vs 200-day
+20.5%

Revenue

$24.40B+323.52%
$4.96B$11.44B$17.92B$24.40B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$23.59
$23.02–$24.37
18 analysts
FY2026
$35.46+50% YoY
$32.77–$36.25
15 analysts
FY2027
$50.68+43% YoY
$44.37–$59.77
16 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
David A. Ricks
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
50,000
Beta
0.45
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
9.09
www.lilly.com